Special
Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Dermapharm Holding SE: A reportable insider transaction was published on 15th November 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 15th November 2024,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft 
. The transaction toke place on 14th November 2024. . The aggregated volume was 6.464.000,00 EUR, based on an average price of 32,32 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 11th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 11th November 2024,
The Insider Transaction was made by Feldmeier, Dr. Hans-Georg . The transaction toke place on 8th November 2024. The order was executed at the trading place Deutsche Börse - Frankfurt Xetra. . The aggregated volume was 95.185,00 EUR, based on an average price of 31,73 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 5th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th November 2024,
The Insider Transaction was made by Dreibholz, Christof . The transaction toke place on 4th November 2024. The order was executed at the trading place Tradegate Exchange. . The aggregated volume was 27.720,00 EUR, based on an average price of 30,80 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 23rd October 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 23rd October 2024,
The Insider Transaction was made by Lanz, Susanne Gertrud Pia . The transaction toke place on 22nd October 2024. The order was executed at the trading place Deutsche Börse - Frankfurt Xetra. . The aggregated volume was 19.704,55 EUR, based on an average price of 31,88 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 29th August 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 29th August 2024,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 28th August 2024. . The aggregated volume was 29.954.600,00 EUR, based on an average price of 36,53 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 11th June 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 11th June 2024,
The Insider Transaction was made by Lanz, Susanne Gertrud Pia . The transaction toke place on 10th June 2024. The order was executed at the trading place Deutsche Börse Frankfurt. . The aggregated volume was 101.778,57 EUR, based on an average price of 36,95 EUR. The nature of the Investment was Buy.
Dermapharm AG: A reportable insider transaction was published on 22nd May 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 22nd May 2024,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 16th May 2024. . The aggregated volume was 8.577.500,00 EUR, based on an average price of 34,31 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 10th April 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 10th April 2024,
The Insider Transaction was made by Beier, Wilhelm . The transaction toke place on 5th April 2024. . The aggregated volume was 1.980.000,00 EUR, based on an average price of 33,00 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 28th March 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 28th March 2024,
The Insider Transaction was made by Schorn, Anja . The transaction toke place on 28th March 2024. The order was executed at the trading place XETRA. . The aggregated volume was 49.337,70 EUR, based on an average price of 32,89 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 23rd November 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 23rd November 2023,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 21st November 2023. . The aggregated volume was 15.216.000,00 EUR, based on an average price of 38,04 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 27th June 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th June 2023,
The Insider Transaction was made by Feldmeier, Dr. Hans-Georg . The transaction toke place on 23rd June 2023. The order was executed at the trading place Frankfurt. . The aggregated volume was 99.902,36 EUR, based on an average price of 44,96 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 4th April 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 4th April 2023,
The Insider Transaction was made by Dreibholz, Katharina . The transaction toke place on 31st March 2023. The order was executed at the trading place Xetra. . The aggregated volume was 449,04 EUR, based on an average price of 34,42 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 4th April 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 4th April 2023,
The Insider Transaction was made by Dreibholz, Benjamin . The transaction toke place on 31st March 2023. The order was executed at the trading place Xetra. . The aggregated volume was 449,28 EUR, based on an average price of 37,44 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 3rd April 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 3rd April 2023,
The Insider Transaction was made by Dreibholz, Christof . The transaction toke place on 31st March 2023. The order was executed at the trading place Xetra. . The aggregated volume was 49.024,00 EUR, based on an average price of 37,71 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 11th January 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 11th January 2023,
The Insider Transaction was made by Dreibholz, Christof . The transaction toke place on 10th January 2023. The order was executed at the trading place Tradegate Exchange. . The aggregated volume was 49.638,00 EUR, based on an average price of 38,18 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 14th October 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 14th October 2022,
The Insider Transaction was made by Feldmeier, Dr. Hans-Georg . The transaction toke place on 14th October 2022. The order was executed at the trading place Frankfurt. . The aggregated volume was 98.900,00 EUR, based on an average price of 39,56 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 13th October 2022. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 13th October 2022,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 12th October 2022. . The aggregated volume was 55.825.000,00 EUR, based on an average price of 38,50 EUR. The nature of the Investment was Buy.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 58 | 14th November 2024 | EQS Group AG | EQS |
| Corporate Research | 0 | - | - | Corporate Research |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.